Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 14, 2013 - Issue 5
Submit an article Journal homepage
747
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Polycythemia vera: current pharmacotherapy and future directions

Benjamin HensleyMayo Clinic, Department of Internal Medicine, Scottsdale, AZ, USA
, DO,
Holly GeyerMayo Clinic, Department of Internal Medicine, Scottsdale, AZ, USA
, MD &
Ruben MesaMayo Clinic, Department of Hematology and Medical Oncology, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA+1 480 301 8000; +1 480 301 1388; [email protected]
, MD
Pages 609-617 | Published online: 12 Mar 2013

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Lynda Foltz, Gian-Matteo Pica, Hacene Zerazhi, Jan Van Droogenbroeck, Sorin Visanica, Enrique Báez de la Fuente, Brian Leber, Antonio Medina de Almeida, Dana Ranta, Jean-Jacques Kiladjian, Linda Chrit, Albert Kandra, Juliane Morando & Timothy Devos. (2019) Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available. Leukemia & Lymphoma 60:14, pages 3493-3502.
Read now
Chad C Cherington, Krisstina L Gowin & Ruben A Mesa. (2015) Ruxolitinib for treatment of polycythemia vera. Expert Opinion on Orphan Drugs 3:9, pages 1085-1096.
Read now
Marina Kremyanskaya, John Mascarenhas & Ronald Hoffman. (2015) Anagrelide hydrochloride and ruxolitinib for treatment of polycythemia vera. Expert Opinion on Pharmacotherapy 16:8, pages 1185-1194.
Read now
Farah Shariff & Claire Harrison. (2013) Polycythemia vera: can we do better?. Expert Opinion on Pharmacotherapy 14:6, pages 687-689.
Read now

Articles from other publishers (11)

Norio Komatsu, GyungJin Jun, Toshio Yonezu & Yasuo Ohashi. (2020) Real-world, retrospective study evaluating thromboembolic events, associated risk factors, and health-care resource utilization in Japanese patients with polycythemia vera. International Journal of Hematology 112:2, pages 176-184.
Crossref
Joshua F. Zeidner, Darshan Roy, Alexander Perl & Ivana Gojo. 2018. The American Cancer Society's Oncology in Practice. The American Cancer Society's Oncology in Practice 397 421 .
Jean-Jacques Kiladjian, Paola Guglielmelli, Martin Griesshammer, Guray Saydam, Tamas Masszi, Simon Durrant, Francesco Passamonti, Mark Jones, Huiling Zhen, Jingjin Li, Brian Gadbaw, Julian Perez Ronco, Mahmudul Khan & Srdan Verstovsek. (2018) Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies. Annals of Hematology 97:4, pages 617-627.
Crossref
Keita Kirito, Kenshi Suzuki, Koichi Miyamura, Masahiro Takeuchi, Hiroshi Handa, Shinichiro Okamoto, Brian Gadbaw, Kyosuke Yamauchi, Taro Amagasaki, Kazuo Ito & Masayuki Hino. (2017) Ruxolitinib is effective and safe in Japanese patients with hydroxyurea-resistant or hydroxyurea-intolerant polycythemia vera with splenomegaly. International Journal of Hematology 107:2, pages 173-184.
Crossref
Suguru Tamura, Keisuke Kawamoto, Hiroaki Miyoshi, Takaharu Suzuki, Takayuki Katagiri, Takuya Kasami, Hiroki Nemoto, Shukuko Miyakoshi, Hironori Kobayashi, Yasuhiko Shibasaki, Masayoshi Masuko, Kengo Takeuchi, Koichi Ohshima, Hirohito Sone & Jun Takizawa. (2018) Cladribine treatment for Erdheim–Chester disease involving the central nervous system and concomitant polycythemia vera: A case report. Journal of Clinical and Experimental Hematopathology 58:4, pages 161-165.
Crossref
Andreas Reiter & Claire Harrison. (2016) How We Identify and Manage Patients with Inadequately Controlled Polycythemia Vera. Current Hematologic Malignancy Reports 11:5, pages 356-367.
Crossref
J. C. Furlan, J. Fang & F. L. Silver. (2016) Acute ischemic stroke and abnormal blood hemoglobin concentration. Acta Neurologica Scandinavica 134:2, pages 123-130.
Crossref
GYEONGMIN JEONG, JINHYONG KIM, SEEUN HAN, JONGMIN LEE, KYUNGHYE PARK, CHUIYONG PAK, JI-HUN LIM, HEE JEONG CHA, HAWK KIM & JAE-CHEOL JO. (2016) Coexistence of follicular lymphoma and an unclassifiable myeloproliferative neoplasm in a treatment-naïve patient: A case report. Oncology Letters 11:2, pages 1469-1473.
Crossref
Chul Won Choi, Soo-Mee Bang, Seongsoo Jang, Chul Won Jung, Hee-Jin Kim, Ho Young Kim, Soo-Jeong Kim, Yeo-Kyeoung Kim, Jinny Park & Jong-Ho Won. (2015) Guidelines for the management of myeloproliferative neoplasms. The Korean Journal of Internal Medicine 30:6, pages 771-788.
Crossref
Martin Griesshammer, Heinz Gisslinger & Ruben Mesa. (2015) Current and future treatment options for polycythemia vera. Annals of Hematology 94:6, pages 901-910.
Crossref
Laura Breda & Stefano Rivella. (2014) Modulators of Erythropoiesis. Hematology/Oncology Clinics of North America 28:2, pages 375-386.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.